Molecular Profiling of Endocrine Resistance in HR+/HER2-Metastatic Breast Cancer: Insights from Extracellular Vesicles-Derived DNA and ctDNA in Liquid Biopsies
Ana Martínez-Rodríguez, Jesús Fuentes-Antrás, Víctor Lorca, Alfonso López de Sá, Pedro Pérez-Segura, Fernando Moreno, Jose Angel García-Sáenz, Vanesa García-Barberán, Mi Kyung Park · 2024
Read Molecular Profiling of Endocrine Resistance in HR+/HER2-Metastatic Breast Cancer: Insights from Extracellular Vesicles-Derived DNA and ctDNA in Liquid Biopsies by Ana Martínez-Rodríguez, Jesús Fuentes-Antrás, Víctor Lorca, Alfonso López de Sá, Pedro Pérez-Segura, Fernando Moreno, Jose Angel García-Sáenz, Vanesa García-Barberán, Mi Kyung Park (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11641624.txt.
Description
Martínez-Rodríguez and co-authors read DNA from tiny parcels shed by tumors to foresee hormone therapy failure in metastatic breast cancer, in a 2024 study. They followed fifty-nine patients whose cancers feed on hormones, checking two resistance-linked genes in DNA from extracellular vesicles and in ordinary circulating tumor DNA.
One gene's mutations, in ESR1, appeared in a quarter of patients, and finding them in vesicle DNA at baseline meant faster progression, especially on one drug. The other gene told a different story depending on the source: silent in vesicle DNA, ominous in circulating DNA. The authors argue the two liquid biopsy sources complement each other.
Catalog record
| CREATOR | Ana Martínez-Rodríguez, Jesús Fuentes-Antrás, Víctor Lorca, Alfonso López de Sá, Pedro Pérez-Segura, Fernando Moreno, Jose Angel García-Sáenz, Vanesa García-Barberán, Mi Kyung Park |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |